Investor Briefing ( Oct, 2024 )

◆   Financials（Rate: 7.0, September 30th, 2024）

Sunresin unveiled its Q3 2024 financial report on October 24th, highlighting growth across its diverse business segments, particularly in international markets. The company's hight-gross-profit product lines are experiencing good expansion, with the electronic grade, panel, and photovoltaic sectors seeing a continuous rise in demand for UPW resins. These products are undering ongoing certification and testing, and the company has reported a consistent increase in order volumes.

◆   CPHI Milan 2024

Sunresin participated in CPHI Milan 2024 from October 8th to 10th, showcasing its range of products in synthetic purification, catalysts, and solid-phase peptide synthesis carriers. Alessandra Basso, the Global Sales and Marketing Director of Sunresin life science division, was interviewed at the event, where she highlighted Sunresin's contributions to the pharmaceutical industry and discussed the company's internationalization strategy, its commitment to fostering a global work environment, and its efforts to promote the professional growth of women within the organization.

◆   Sunresin Scored an A-Level Rating Once More from SZSE

Sunresin has once again achieved an A-level rating in the Shenzhen Stock Exchange's (SZSE) 2023 annual information disclosure evaluation, marking its second consecutive year at the top. This prestigious recognition reflects commitment to high-quality corporate governance and investor relations.Sunresin is fully committed to the pursuit of innovation, standard-ization, and transparency, aiming to contribute to the development of a robust, multi-tiered and mutually beneficial capital market ecosystem.

Contact Us